Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease non-alcoholic fatty liver disease
Comorbidity |obesity
Sentences 164
PubMedID- 21810560 Many genes encoding mitochondrial proteins in skeletal muscle and fat are negatively correlated with body mass [8,24,25] nafld is commonly associated with obesity and insulin resistance; both conditions are characterized by decreased oxygen consumption, atp production, and reduced content of respiratory proteins in the fat, muscle and liver [8].
PubMedID- 24748893 Childhood obesity may lead to nafld in every age group.
PubMedID- 24232498 Mice fed an i3o-supplemented hfd also showed a decrease in non-alcoholic fatty liver, a condition associated with obesity in which deposits of fat cause the liver to become enlarged and exhibit a milky pale color, showing evidence of lipid accumulation (figure 3c).
PubMedID- 21278140 nafld is closely associated with abdominal obesity (14).
PubMedID- 22966224 Hepatic steatosis without excessive alcohol intake, called nonalcoholic fatty liver disease (nafld), is commonly associated with obesity and insulin resistance [1, 2].
PubMedID- 22194737 The reported prevalence of obesity in patients with nafld varies from 30 to 100% [8] and increases with increasing bmi.
PubMedID- 20731535 nafld is strongly associated with insulin resistance, obesity, hypertension, and dyslipidemia and is now regarded as the liver manifestation of the metabolic syndrome (3).
PubMedID- 22374640 Fourth, obesity in nafld is associated with dysfunctional adipose tissue and lipotoxicity that promotes ir (19,21,27) and pancreatic β-cell dysfunction (28,29).
PubMedID- 26439744 Since nafld is closely associated with obesity, insulin resistance and type 2 diabetes[11–13], it is suspected that adipose tissue and skeletal muscle may play an important role in the development of nafld.
PubMedID- 25993257 In addition to cardiovascular comorbidities, obesity is also associated with non-alcoholic fatty liver disease (nafld), the hepatic expression of the ms [3].
PubMedID- 26395497 Similar patterns were inferred for mets components on nafld, with obesity having the greatest (16.37%) effect, followed by diabetes (10.85%), dyslipidemia (10.74%) and hypertension (7.36%).
PubMedID- 22087177 nafld is frequently associated with obesity, diabetes mellitus and the metabolic syndrome.
PubMedID- 24130687 Several studies have suggested that vitamin d deficiency and nafld are commonly associated with central obesity and insulin resistance [2], [8], [9].
PubMedID- 20370671 nafld is strongly associated with obesity, insulin resistance, hypertension and dyslipidaemia and is now regarded as the liver manifestation of the metabolic syndrome.

Page: 1 2 3 4